Navigation Links
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Date:9/22/2009

revent the proliferation of tumor cell lines while promoting apoptosis (cell death) by directly targeting several oncogenic TK receptors. The clinical significance of these studies is not known and warrant further investigation in a broad spectrum of tumors.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a subsidiary of Bayer Corporation. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. The company's aim is to provide products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Details on the studies and the abstract #7105 can be found on the ECCO 15 - 34th ESMO website: http://www.ecco-org.eu/Conferences-and-Events/ECCO-15/page.aspx/216.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever t
'/>"/>

SOURCE Bayer HealthCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 With advancements in neurological ... market is seeing new growth, according to Kalorama ... account for the majority of market volume, newer ... images, which are creating opportunities for more sophisticated applications. ... growing at a rate of 4%, with world ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... Nov. 12 A new treatment for autism appears ... S. Starr, MD, FAACAP, BCIA-EEG. , In ... characteristically common "u" EEG pattern reflecting impaired brain function, ... interaction, communication, speech and bonding. , ...
... MINNEAPOLIS/ST. PAUL, Nov. 12 /PRNewswire / -- ... for Integrative Oncology,s (SIO) Sixth International Conference in ... and safety of complementary and alternative medicine (CAM) ... Director, Hematology/Oncology at Children,s Hospitals and Clinics of ...
Cached Medicine Technology:New Treatment for Autism 'Holds Promise' 2New Treatment for Autism 'Holds Promise' 3New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies 2
(Date:12/21/2014)... 21, 2014 When families in Coral Gables ... they call? The new answer is Lice Troopers . ... 33134, their newest treatment center will be the new go-to ... and without the use of harmful chemicals or pesticides. ... January 1, 2015. Like the company’s first clinic (located at ...
(Date:12/21/2014)... The number of Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... in New Jersey, Bernstein Liebhard LLP reports. , According ... the birth control IUD have now been filed in ... women who allege spontaneous migration of the device, which ... other complications they were inadequately warned about by its ...
(Date:12/21/2014)... OR (PRWEB) December 21, 2014 ... some of the issues and systemic barriers for disabled ... World Paratriathlon Champion. Scheidies has a condition called juvenile ... time. He describes how he adapted his athletic ambitions ... use his success in triathlon to pioneer the way ...
(Date:12/21/2014)... Fairfax, Virginia (PRWEB) December 21, 2014 Concept ... management and engineering firm headquartered in Fairfax, VA., today ... part of its Fast 50 list, which ranks the fastest ... growth rate from 2009 to 2013. , This is the ... 50 and it ranked # 20 with a 95.92% compound ...
(Date:12/20/2014)... York, NY (PRWEB) December 20, 2014 ... the healthcare sector have benefited the Massage Services ... the discretionary characteristics of industry products, the anticipated 1.0% ... five-year period has provided consumers with the means to ... that have received a massage in a given year ...
Breaking Medicine News(10 mins):Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... Offer for The, Health, Educational and Housing Facility Board of ... (Methodist ... and Housing Facility Board of the County of Shelby, Tennessee ... ...
... close relatives proposed , , FRIDAY, Sept. 7 (HealthDay News) ... close relatives of people with coronary heart disease could ... Scottish researchers say. , "If you want primary prevention, ... groups with high risk," explained Dr. Jill Pell, professor ...
... who,purchased raw milk from the Amos B. King dairy ... should discard it immediately due to the risk of,campylobacterosis ... is milk that has not been pasteurized or homogenized. ... test showed the,presence of campylobacter bacteria in some raw ...
... Would Establish Rules for Union Process, FRESNO, Calif., ... a message to CEO Tim Joslin on,Thursday: the union-busting ... the quality of treatment offered there at risk. ... and fair election,agreement with employees who are interested in ...
... Documents to New York, Times and ... Sanctions, INDIANAPOLIS, Sept. 7 Eli Lilly ... Dr. David Egilman, a former,plaintiffs, expert witness in ... admitted violating a protective order in the Zyprexa,litigation ...
... As states consider,proposals to expand access to health ... prior efforts in states across the country. Over ... with significant,unintended consequences. A number of these initiatives ... of implementation. The study by,Milliman, Inc. on behalf ...
Cached Medicine News:Health News:Memphis Hospitals announces debt tender offer 2Health News:Family History Has Strong Effect on Cardiac Risk 2Health News:Family History Has Strong Effect on Cardiac Risk 3Health News:Hospital Workers: Management Threatens Patient Care 2Health News:Statement of Eli Lilly and Company on Dr. David Egilman Settlement: 2Health News:Statement of Eli Lilly and Company on Dr. David Egilman Settlement: 3Health News:Statement of Eli Lilly and Company on Dr. David Egilman Settlement: 4Health News:New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market 2
The safePICO is a prebarcoded arterial sampler that helps you ensure patient and caregiver safety. SafePICO is part of 1st automatic, the worlds first automatic blood gas analysis system....
Measure SpO2 and tcpCO2 with a single sensor....
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2....
... components that comprise the SmartPill GI ... comprise the SmartPill GI Monitoring System: ... Receiver software and SmartPill MotiliGI software. ... indispensable parts of the SmartPill GI ...
Medicine Products: